LD-2 disclosure · 4th Quarter - Report
VERTEX PHARMACEUTICALS INCORPORATED
Client
- Location
- Massachusetts · United States of America
Registrant
- Description
- Global biotechnology company
- Location
- Boston, Massachusetts, United States of America
Lobbying activities
3 issuesHealth Issues
General education about federal policies impacting pharmaceutical development, approval, and reimbursement; Patient access to non-opioid pain medicines; Issues related to FDA drug approval process; Copay accumulators and maximizers, HELP Copays Act (H.R. 830/S. 1375); General education about Alternative Funding Programs; Pandemic All-Hazards Preparedness Act reauthorization, including new authorities requested by FDA.
LobbyistsMATTHEW O SCHUMAKER · SWARNA VALLURUPALLI · ERIN MENDELSOHN · ms HANNAH BETH CORNWELL · ms KRISTIN RICHTER
Covered position (ERIN MENDELSOHN): LD, Rep Eshoo (Jan 2013 - May 2015); Congressional Liaison - FDA (May 2015 - Feb 2018); Rep. Harman - Staff Assistant (Jun 2005 - Jun 2006); Rep. Eshoo - Leg. Correspondent, Leg. Assistant, Senior Leg. Assistant (Jan 2005 - Jan 2013).
TargetedSENATE · HOUSE OF REPRESENTATIVES
Taxation/Internal Revenue Code
Issues related to corporate and international tax policy and research and development tax credits, American Innovation and R&D Competitiveness Act (H.R. 2673) and American Innovation and Jobs Act (S. 866)
LobbyistsMATTHEW O SCHUMAKER · SWARNA VALLURUPALLI
TargetedSENATE · HOUSE OF REPRESENTATIVES
Medicare/Medicaid